Abstract. Tetrandrine (TET), a bis-benzylisoquinoline alkaloid from the root of Stephania tetrandra, is known to possess antitumor activity in various malignant neoplasms. However, the precise mechanism of TET-mediated immune modulation remains to be clarified. One of the possible mechanisms for its protective properties is by downregulation of the inflam matory responses. In the present study, the human mast cell line (HMC1) was used to investigate this effect. TET significantly inhibited the induction of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-8 by phorbol 12-myristate 13-acetate (PMA) plus A23187. Moreover, TET attenuated expression of cyclooxygenase (COX)-2. In activated HMC-1 cells, the phosphorylation of extra-signal response kinase (ERK1/2) and c-jun N-terminal Kinase (JNK1/2), but not p38 mitogen-activated protein kinase, was decreased by treatment of the cells with TET. TET inhibited PMA plus A23187-induced nuclear factor (NF)-κB activation, IκB degradation and phosphorylation. Furthermore, TET suppressed the expression of TNF-α, IL-8, IL-6 and COX-2 through suppression of the ERK1/2, JNK1/2, IκBα degradation and phosphorylation, and NF-κB activation. These results indicated that TET exerted a regulatory effect on inflammatory reactions mediated by mast cells.
Introduction
Tetrandrine (International Union of Pure and Applied Chemistry name: 6, 6', 7, 12-tetramethoxy-2, 2'-dimethyl-1β-berbaman; Chemical Abstracts Service no. 518-34-3; C 38 H 42 N 2 O 6 ; molecular weight, 622.74988; TET; molecular structure of TET shown in Fig. 1 ) is a bis-benzylisoquinoline alkaloid from the root of Stephania tetrandra that has been used in China for several decades for the treatment of arthritis, arrhythmia, inflammation and silicosis (1) . TET has been shown to exhibit antifibrotic activity in silicosis (2, 3) . Early findings showed that TET may be useful in the therapy of chronic inflammatory diseases in which IL-1 or TNF play a role in pathogenesis (4, 5) . TET was reported to inhibit cell proliferation in various types of cancer cells (6) . However, the antiinflammatory effects of TET on mast cellmediated antiinflammation and cell regulation have not yet been reported.
Inflammation is part of the complex biological response of vascular tissues to harmful stimuli, such as pathogens, damaged cells, or irritants (7) . Mast cells are one of the major effector cells in the immune response system, which respond to the danger signals of innate and acquired immunity with immediate and delayed releases of inflammatory mediators. In allergic inflammation, humans produce immunoglobulin E (IgE) against allergen infiltration resulting in the activation of mast cells which release histamine, tumor necrosis factor-α (TNF-α), interleukin (IL)-6, IL-8, and NF-κB (8) . The results of those studies demonstrated that NF-κB activation and the subsequent activation of proinflammatory cytokine gene expression are critically important in the initiation and perpetuation of allergic inflammation. Moreover, NF-κB activation was reported to be required for the expression of a number of inflammatory proteins such as GM-CSF, TNF-α, IL-6, COX-2 and inducible nitric oxide synthase (iNOS) (9) . Therefore, the inhibition of NF-κB was able to reduce the expression of inflammatory genes and it is a mechanism by which antiinflammatory agents potentially elicit their antiinflammatory effects (10) .
Mitogen-activated protein kinases (MAPKs) belong to a large family of proline-directed serine/threonine protein kinases that play a fundamental role in cell functions. The activation of MAPK proceeds through a cascade of upstream molecules in an orderly manner. The inhibition of MAPK activity pharmacological or genetic approaches blocks allergic inflammation of airways. Specifically, ERK1/2 is important for mast cell differentiation/proliferation, survival and eicosanoid release (11-13).
Tetrandrine suppresses pro-inflammatory mediators in PMA plus A23187-induced HMC-1 cells
In the present study, we investigated the potential effects of TET on the production of inflammatory cytokines in the human mast cell line (HMC-1). Subsequently, the effects of TET were evaluated on PMA plus A23187-induced expression of proinflammatory mediators by inhibiting MAPK and IκBα/NF-κB signaling pathways.
Materials and methods
Reagents. Tetrandrine was purchased from Sigma-Aldrich and was dissolved in dimethyl sulfoxide (DMSO). The final DMSO concentration was adjusted to <0.01% (v/v) in the culture media. PMA, the calcium ionophore A23187 (Calcymycin; C 29 H 37 N 3 O 6 ), and 3-[4,5-dimetylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) were purchased from the Sigma Chemical Co. (St. Louis, MO, USA). Iscove's modified Dulbecco's medium (IMDM) was obtained from Gibco BRL (Grand Island, NY, USA). Anti-human TNF-α, IL-6 and IL-8 antibodies, biotinylated anti-human TNF-α, IL-6 and IL-8 antibodies, and recombinant human TNF-α, IL-6 and IL-8 were purchased from BD PharMingen (San Diego, CA, USA). The COX-2, β-actin, NF-κB, pIκB, IκB and MAPKs (P-ERK1/2, P-JNK1/2, P-p38 MAPK, ERK1/2, JNK1/2, and p38 MAPK) antibodies were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). SYBR Premix Ex Taq™ was purchased from Takara Bio, Inc. (Shiga, Japan).
Primer design. Sequences of oligonucleotide primers were designed for real-time PCR using Primer Express ® software (Takara, Dalian, China) ( Table I) .
Cell culture. HMC-1 cells were cultured in IMDM and supplemented with 100 U/ml of penicillin, 100 µg/ml of streptomycin, and 10% fetal bovine serum (FBS) at 37˚C in 5% CO 2 with 95% humidity. The HMC1 cells were treated with TET (10-50 µM) for 1 h. The cells were then stimulated with 50 nM of PMA plus 1 µM of A23187 and incubated at 37˚C for the indicated time periods (30 min-24 h).
MTT assay. For the MTT colorimetric assay of cell survival, we used a method described by Kang et al (14) with minor modifications. Cell aliquots were seeded (3x10 5 ) in microplate wells and incubated with 20 µl of an MTT solution (5 mg/ml) for 4 h at 37˚C under 5% CO 2 and 95% air. This was followed by the addition of 100 µl of DMSO in order to extract the MTT formazan. An automatic microplate reader (Molecular Devices, Sunnyvale, CA, USA) was used to read the absorbance of each well at 540 nm.
Cytokine assay. The HMC-1 cells were pretreated with various concentrations of TET (10-50 µM) for 1 h prior to PMA plus A23187 stimulation. Enzyme-linked immunosorbent assay (ELISA) was used to assay the culture supernatant for the TNF-α, IL6 and IL8 protein levels. To measure the cytokine, a modified ELISA method was utilized. A sandwich ELISA was initially conducted for TNF-α, IL-6 and IL-8 in duplicate in 96-well ELISA plates (Nunc, Roskilde, Denmark). The supernatant was decanted into a new microcentrifuge tube and the cytokine were quantified by ELISA. ELISA plates (Falcon, BectonDickinson Labware, Franklin Lakes, NJ, USA) were coated overnight at 4˚C with antihuman TNFα, IL-6 and IL-8 monoclonal antibodies diluted in coating buffer (0.1 M carbonate, pH 9.5) and then washed four times with phosphate-buffered saline (PBS) containing 0.05% Tween20. The nonspecific protein binding sites were blocked with assay diluent (PBS containing 10% FBS, pH 7.0) for at least 1 h. After washing the plates again, the test sample or recombinant TNF-α, IL-6 and IL-8 standards were added. Following incubation for 2 h, a working detector (biotinylated antihuman TNFα, IL6 and IL8, monoclonal antibodies and strepta vidin-horseradish peroxidase reagent) was added and incubated for 1 h. Accordingly, substrate solution (tetramethylbenzidine) was added to the wells and incubated for 30 min in the dark before the reaction was stopped with a solution of 1 M H 3 PO 4 . The absorbance was read at 450 nm. All subsequent steps occurred at room temperature, and all standards and samples were assayed in duplicate.
Reverse transcriptase-polymerase chain reaction (RT-PCR) and quantitative RT-PCR analysis.
Using a GeneAllR RiboEx RNA extraction kit (GeneAll Biotechnology, Republic of Korea), total RNA was isolated from HMC-1 cells according to the manufacturer's specifications. The concentration of total RNA in the final eluate was determined by spectrophotometry (Thermo Fischer Scientific Inc., Waltham, MA, USA). The total RNA (2.0 µg) was heated at 65˚C for 10 min and then cooled on ice. A cDNA synthesis kit (iNtRON Biotech, Republic of Korea) was used for 90 min at 37˚C to reversetranscribe each sample to cDNA. Primer sequences for TNF-α, IL-6, IL-8, COX-2 and β-actin were used for PCR analysis as previously described (15) . The PCR products increased as the concentration of RNA increased. The products were electrophoretically resolved on a 2.0% agarose gel and visualized by staining with ethidium bromide. The levels of TNF-α, IL6, IL8 and βactin mRNA were measured with the realtime reverse transcription (RT)-PCR method using SYBR-Green. Total RNA was extracted from the cells with an RNeasy ® Mini kit (Qiagen Inc., Valencia, CA, USA). Aliquots (1 µg) of total RNA were used for RT, using a Prime Script TM RT reagent kit (Takara Bio, Inc.) and a Smart cycler ® II System; Takara Bio, Inc.). The RT reaction was performed in a total volume of 20 µl using a SYBR Premix Ex Taq (Takara Bio, Inc.), with 2 µl of the cDNA sample being used as a template. The sequences are shown in Table I . Cycling was initiated with an activation step at 95˚C for 10 sec, and an amplification program was repeated 45 times (denaturation, 95˚C for 5 sec; annealing/extension, 60˚C for 20 sec) with fluorescence measurement at 72˚C.
The fluorescence of the SYBRGreen dye was determined as a function of the PCR cycle number. In order to confirm amplification specificity, the PCR products from each primer pair were subjected to a melting curve analysis. The ∆CT values (Ct = cycle threshold value) for the housekeeping gene (β-actin) and the target gene (TNF-α, IL-6 and IL-8) were calculated by subtracting the experiment group (PMA + A23187 + TET) from the control (non-stimulated value). The relative expression of the target gene was calculated on the basis of 2-∆(∆Ct). The ∆(∆Ct) values were calculated by subtracting the drug treated (PMA + A23187 + TET) ∆Ct from the control (PMA + A23187) ∆Ct.
Preparation of cytoplasmic and nuclear extracts. Nuclear and cytoplasmic extracts were prepared as described previously (14) . Briefly, following activation of the cells for the time periods indicated, 5x10 6 cells were washed with ice-cold PBS and centrifuged at 15,000 x g for 1 min. The cells were resuspended in 40 µl of a cold hypotonic buffer [10 mM Hepes/ KOH, 2 mM MgCl 2 , 0.1 mM EDTA, 10 mM KCl, 1 mM DTT, and 0.5 mM PMSF, pH 7.9]. The cells were allowed to swell on ice for 15 min, followed by gentle lysis with 2.5 µl of 10% Nonide P (NP)-40 and then centrifugation at 15,000 x g for 3 min at 4˚C. The supernatant was collected and used as the cytoplasmic extract. The nuclear pellets were gently resuspended in 40 µl of cold saline buffer [50 mM HEPES/KOH, 50 mM KCl, 300 mM NaCl, 0.1 mM EDTA, 10% glycerol, 1 mM DTT, and 0.5 mM PMSF, pH 7.9] and left on ice for 20 min. Following centrifugation (15,000 x g for 15 min at 4˚C), the aliquots of the supernatant containing nuclear proteins were frozen in liquid nitrogen and stored at 70˚C until ready for analysis. The bicinchoninic acid protein assay (Sigma Chemical Co.) was used for protein quantification.
Western blot analysis. The HMC-1 cells (5x10 6 cells/well) were stimulated with PMA (50 nM) plus A23187 (1 µM). Cell lysates were prepared in a sample buffer containing sodium dodecyl sulfate (SDS). The samples were heated at 95˚C for 5 min and briefly cooled on ice. Following centrifugation at 15,000 x g for 5 min, the proteins in the cell lysates were separated by 10% SDSpolyacrylamide gel electrophoresis (SDSPAGE) and transferred to a nitrocellulose membrane. The membrane was then blocked with 5% skim milk in PBS Tween20 for 1 h at room temperature and then incubated with primary antibody. After washing the blot in PBS Tween-20 three times, it was incubated with a secondary antibody for 1 h and then the antibodyspecific proteins were visualized using an enhanced chemiluminescence detection system as per the manufacturer's instructions (Amersham Corp., Newark, NJ, USA).
Statistical analysis. Statistical analysis was performed using one-way analysis of variance (ANOVA) followed by Dunnett's t-test for multiple comparisons, and the Student's test for single comparisons. The data from the experiments are presented as means ± SEM. The number of independent experiments assessed are provided in the figure legends.
Results

Effects of TET on cytotoxicity in HMC-1 cells.
The cyto toxicity of TET was evaluated using MTT assay, and TET was found not to affect HMC-1 cell viability at concentrations of 10 and 50 µM. However, the cytotoxicity of TET was evaluated to be at a high concentration of 100 µM (Fig. 2) .
Effects of TET on pro-inflammatory cytokine production.
To evaluate the potential effects of TET on the production of proinflammatory cytokines, the cells were pretreated with TET (10 and 50 µM) prior to stimulation with PMA (50 nM) and A23187 (1 µM) for 8 h, and further analysis using ELISA was carried out. As shown in Fig. 3 , the levels of TNF-α, IL-6, and IL-8 were considerably increased after stimulation with PMA plus A23187 in HMC-1. Pretreatment of cells with TET (10 and 50 µM) significantly inhibited the increase of these protein levels in a concentration-dependent manner. The The primers pairs were designed using Primer Express ® software.
maximal inhibition of TNF-α, IL-6 and IL-8 production by TET (50 µM) was ~70, 71 and 88%, respectively.
Effects of TET on pro-inflammatory cytokine gene expression.
The proinflammatory cytokine gene expression was analyzed using RT-PCR and RT-qPCR. Enhanced TNF-α, IL-6 and IL-8 mRNA expression induced by PMA plus A23187 was inhibited by the pretreatment of the cells with TET (Fig. 4) .
In particular, pretreatment with TET at a concentration of 10 and 50 µM inhibited the PMA and A23187-induced gene expression of TNF-α, IL-6 and IL-8.
Effects of TET on COX-2 protein and COX-2 mRNA expression.
In recent studies, the important roles of COX-2 in mast cell-mediated inflammation have been demonstrated (16) . Thus, to determine the effects of TET on COX-2 protein and COX-2 mRNA expression induced by PMA plus A23187, western blot and RT-PCR analysis were conducted. The cells were pretreated with TET (10 and 50 µM) for 1 h and then treated with PMA plus A23187. As shown in Fig. 5 , TET inhibited the PMA plus A23187-induced COX-2 protein and COX-2 mRNA expression.
Effects of TET on activation of MAPKs.
To evaluate the mechanisms underlying the effects of TET, we examined the potential effects of TET on activation of MAPKs. The stimulation of HMC-1 cells with PMA plus A23187 resulted in an increased phosphorylation of all three types of MAPKs, p38, JNK and ERK, after 15-30 min (data not shown). As shown in Fig. 6 , TET attenuated PMA plus A23187-induced phosphorylation of ERK1/2 and JNK1/2, but did not affect the phosphorylation of p38 MAPK.
Effects of TET on NF-κB activation, IκBα phosphorylation and degradation.
The expression of the proinflammatory cytokine tested in this study is known to be regulated by a transcription factor, NF-κB (17) . Therefore, we examined whether TET affects the expression of NF-κB signaling molecules or NF-κB transcriptional activity. To evaluate the mechanism of the effect of TET on the gene expression of proinflammatory cytokines, we examined the possible effects of TET on NF-κB activation. Stimulation of HMC-1 cells with PMA plus A23187 induced the degradation and phosphorylation of IκBα and promoted the nuclear translocation of p65 NF-κB after 2 h of incubation (Fig. 7) . As shown in Fig. 7 , TET inhibited the PMA plus A23187-induced degradation and phosphorylation of IκBα as well as the nuclear translocation of p65 NF-κB.
Discussion
Several studies have previously demonstrated antiinflammatory effects of novel compounds by the modulation of mast cell activation (16) . Natural product-based compounds seem better than synthetic compounds since natural product-based compounds are generally devoid of severe side-effects (18) . Bis-benzylisoquinoline alkaloid, such as TET, has antiinflammatory, immunologic and antiallergenic effects. It has a 'Quinidine-like' anti-arrhythmic effect. It has been isolated from Stephania tetrandra S Moore, and other Chinese and Japanese herbs (19) . Previous studies have reported that TET has vasodilatory properties and can therefore reduce blood pressure (20) . Moreover, TET has potential therapeutic value to prevent excess scarring/fibrosis in conjunctiva following trabeculectomy or in patients with severe conjunctival inflammation (21) . However, the activity of TET on PMA plus A23187-stimulated mast cell activation has not been well investigated. Therefore, in the present study, we investigated whether TET exerts a therapeutic effect on allergic inflammatory disease.
Mast cellderived proinflammatory cytokine, particularly TNF-α, IL-6 and IL-8 have a critical biological role in allergic inflammation. Inflammatory cytokines are important factors in chronic inflammation, allergy, asthma, atherogenesis and autoimmune diseases. Human mast cells play an integral role in the inflammatory response by accumulating at sites of inflammation and mediating the production of inflammatory cytokines, such as IL-6 and IL-8 (22) . Previous studies have indicated that the reduction of pro-inflammatory cytokine from mast cells is one of the key indicators of reduced inflammatory symptoms (16) . The aim of the present study was to examine the effects of TET on the production of TNF-α, IL-6 and IL-8 in HMC-1 cells, as these cytokines have powerful inflammatory effects and are released by activated mast cells. The results showed that TET inhibits TNF-α, IL-6 and IL-8 production in PMA plus A23187-activated mast cells (Fig. 3) . Moreover, RT-PCR and RT-qPCR analysis of the gene expression of the inflammatory cytokines, TNFα, IL-6 and IL-8, revelaed inhibitory effects in PMA plus A23187-stimulated HMC-1 (Fig. 4) . TET blocked COX-2 activation in a dose-dependent manner (Fig. 5) . Therefore, these results showed that TET exerts markedly antiinflammatory effects in PMA plus A23187-stimulated HMC-1.
We investigated whether MAPK activation recognizes the mechanism involved in the effect of TET on proinflammatory cytokine expression in HMC-1 cells. In mammals, three major factors that mediate the MAPK pathways have been identified: ERKs, p38 and stress-activated protein kinases (SAPKs)/JNK (23) . ERKs, p38 and JNK are activated in response to different extracellular stimuli, in that they have different downstream targets and therefore perform different functions, including mediation of apoptosis, proliferation and inflammation (24) . The effect of TET on the activation of MAPK members in selected cell lines has also been reported. In previous studies, TET was shown to inhibit IgE-mediated activation of ERK and JNK but not of p38 MAPK in human cultured mast cells (25) . It was also shown to inhibit the phosphorylation of ERK1/2 and p38 but not of JNK1/2, in LPS-induced macrophages (26) . This discrepancy may arise from differences in stimulation or the cell type. Results of the present study demonstrated that, the activities of MAP kinases were increased by PMA plus A23187, and TET significantly restored the phosphorylation of ERK and JNK but not of p38 MAPK (Fig. 6) . These results suggest that TET inhibited proinflammatory cytokine production via the inhibition of ERK and JNK activation.
Since suppression of NF-κB activation has been associated with antiinflammation, we hypothesized that TET mediated its effects at least partly through the suppression of NF-κB activation. Activation of NF-κB is dependent on the degradation of IκBα, an endogenous inhibitor that binds to NF-κB in the cytoplasm. The role of NF-κB activation and its regulation of cytokine production in inflammation have already been characterized (27) . Expression of the TNF-α, IL-6 and IL-8 genes is dependent on the activation of transcription factor NF-κB in mast cells. Previous studies have reported that the activation of NF-κB increased the expression of COX-2 (15). This suggests that TET inhibits COX-2 expression through the suppression of NF-κB activation in HMC-1. In PMA and A23187-stimulated mast cells, TET decreased the degradation and phospholylation of IκBα, and inhibited the nuclear translocation of p65 NF-κB. Therefore, this demonstrated that TET inhibited the PMA and A23187induced TNFα, IL6, IL8 and COX-2 expression via the attenuation of NF-κB activation. Future studies to confirm the results of the present study, as well as to elucidate the molecular mechanism of action of TET, are currently underway in our laboratory.
In conclusion, TET regulated the production of TNF-α, IL-6, IL-8 in PMA plus A23187-stimulated HMC-1 cells. TET also decreased COX-2 expression. Furthermore, TET inhibited the ERK1/2, JNK1/2 and NF-κB pathways. Therefore, the regulation of the NF-κB signaling pathway by TET in HMC-1 cells is a potentially attractive and characteristic probe for studying mast cell-mediated allergic diseases.
